Lopardo, G., Belloso, W. H., Nannini, E., Colonna, M., Sanguineti, S., Zylberman, V., . . . Group, I. S. (2021). RBD-specific polyclonal F(ab )2 fragments of equine antibodies in patients with moderate to severe COVID-19 disease: A randomized, multicenter, double-blind, placebo-controlled, adaptive phase 2/3 clinical trial. Elsevier.
Cita Chicago Style (17a ed.)Lopardo, Gustavo, et al. RBD-specific Polyclonal F(ab )2 Fragments of Equine Antibodies in Patients with Moderate to Severe COVID-19 Disease: A Randomized, Multicenter, Double-blind, Placebo-controlled, Adaptive Phase 2/3 Clinical Trial. Elsevier, 2021.
Cita MLA (8a ed.)Lopardo, Gustavo, et al. RBD-specific Polyclonal F(ab )2 Fragments of Equine Antibodies in Patients with Moderate to Severe COVID-19 Disease: A Randomized, Multicenter, Double-blind, Placebo-controlled, Adaptive Phase 2/3 Clinical Trial. Elsevier, 2021.